🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John A. Olson

ORCID: 0000-0002-5183-6890

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx”.

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

Journal of Clinical Oncology(2020)10.1200/jco.19.01866
N/A
3.5DataRank · unranked
102 citations

Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina R. Yanez +14 more

The Antiresorptive Effect of GIP, But Not GLP-2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study

Journal of Bone and Mineral Research(2020)10.1002/jbmr.4308
N/A
0DataRank · unranked
32 citations

Nicola Hepp, Jannika Oeke, Morten Steen Hansen, Abbas Jafari, Maria S. Svane +10 more

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Digital Commons@Becker (Washington University School of Medicine)(2020)10.17615/6e7v-pv95
N/A
0DataRank · unranked
1 citations

Tracy Lively, John A. Olson, Robert J. Gray, Virginia Kaklamani, Della Makower +26 more

Single-cell functional analysis of parathyroid adenomas reveals distinct classes of calcium sensing behaviour in primary hyperparathyroidism

UNC Libraries(2020)10.17615/vzb3-f019
N/A
0DataRank · unranked
0 citations

Yuhong Shi, Nancy L. Allbritton, Joyce A. Hogue, James Koh, Yuli Wang +3 more

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer

Annals of Surgical Oncology(2023)10.1245/s10434-022-12972-5
N/A
0DataRank · unranked
21 citations

Vera J. Suman, Hannah F. Wingate, A. Marilyn Leitch, Gary Unzeitig, Judy C. Boughey +4 more

Data from PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer

(2023)10.1158/0008-5472.c.6499523.v1
N/A
0DataRank · unranked
0 citations

Chanpheng Phommaly, Yu Tao, Jeremy Hoog, Jingqin Luo, Charles M. Perou +12 more

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa148
N/A
0DataRank · unranked
115 citations

Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer +23 more

General Trends in the Calnexin-Dependent Expression and Pharmacological Rescue of Clinical CFTR Variants

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.03.647093
N/A
0DataRank · unranked
0 citations

John A. Olson, Minsoo Kim, Catherine Foye, JaNise Jackson, Eli Fritz McDonald +8 more